Stock Price & Analysis

The S1 support level for ARTL Stock is $1.16 ,The R1 resistant level for ARTL Stock is $1.22.

As of the end of day on 2025-02-04, the price of ARTL Stock was $1.16.

The target price for ARTL Stock according to analyst rating is 5.00, with the highest price target at 5.00 and the lowest at 5.00. Analysts have a Moderate Buy rating on ARTL Stock overall.

The market cap of ARTL is $3.8M.

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system (ECS), a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. It is developing a dual cannabinoid agonist for the G protein-coupled receptor (GPCR) that targets a synthetic small molecule program, ART27.13, as a potential treatment for anorexia associated with cancer. Its second program ART26.12, is a small molecule lead product candidate from its platform of inhibitors of fatty acid binding proteins, notably Fatty Acid Binding Protein 5 (FABP5), which is undergoing pre-clinical research as a potential cancer therapeutic, for pain and inflammation, and in anxiety-related disorders, including post-traumatic stress disorder. In addition, the Company is also developing ART12.11 (CBD cocrystal), a solid-state composition of cannabidiol (CBD).

ARTL has a total of 6 employees.